Literature DB >> 16133269

A less invasive, selective, functional neck dissection for papillary thyroid carcinoma.

G Ardito1, F Rulli, L Revelli, F Moschella, G Galatà, E Giustozzi, F Ardito, A M Farinon.   

Abstract

HYPOTHESIS: To describe an alternative lateral neck access in order to perform neck dissection in papillary thyroid carcinoma (PTC) with lymph node involvement.
DESIGN: Prospective (January 2000 to December 2003), 36-month study.
SETTING: Catholic University of Rome and University of "Tor Vergata", Rome, Italy. PATIENTS AND METHODS: Twenty-four consecutive patients with PTC and cervical lymph node metastases were included. Functional neck dissection (FND), unilateral or bilateral, was performed acceding via a lateral dissection through a traditional Kocher incision, running along the superficial fascia of the neck and posteriorly to the sternocleidomastoideus muscle.
RESULTS: Mean age was 39.04+/-13.69 years. Twenty patients were women and four were men. Mean tumour size was 2.5+/-1 cm, while the greatest metastatic lymph node size was 4.5 cm. Minimally invasive, selective FND was performed in all patients associated to total thyroidectomy and central compartment lymph node clearance. Metastatic lymph nodes were found in 142 out of 340 of the lymph nodes dissected.
CONCLUSIONS: Minimally invasive neck dissection seems to carry a lower risk in terms of specific morbidity and allows a quicker recovery and a better aesthetic result. This access has to be considered as a less invasive procedure compared to the other surgical accesses for the radical or modified lateral neck dissection.

Entities:  

Mesh:

Year:  2005        PMID: 16133269     DOI: 10.1007/s00423-005-0568-1

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  19 in total

1.  Bilateral cervical lymph node metastases in well-differentiated thyroid cancer.

Authors:  M Noguchi; T Kumaki; T Taniya; I Miyazaki
Journal:  Arch Surg       Date:  1990-06

Review 2.  The value of lymph-node dissection in patients with differentiated thyroid cancer.

Authors:  S Noguchi; N Murakami
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

Review 3.  Papillary thyroid carcinoma: factors influencing prognosis and current therapy.

Authors:  E L Mazzaferri
Journal:  Semin Oncol       Date:  1987-09       Impact factor: 4.929

4.  Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.

Authors:  D Simon; P E Goretzki; J Witte; H D Röher
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

Review 5.  Differentiated thyroid cancer: "complete" rational approach.

Authors:  E Kebebew; O H Clark
Journal:  World J Surg       Date:  2000-08       Impact factor: 3.352

Review 6.  Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.

Authors:  J F Hamming; C J van de Velde; B M Goslings; G J Fleuren; J Hermans; J F Delemarre; E A van Slooten
Journal:  Surg Gynecol Obstet       Date:  1989-08

7.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

8.  Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors.

Authors:  M F Herrera; C M López-Graniel; J Saldaña; A Gamboa-Domínguez; Y Richaud-Patín; F Vargas-Vorackova; A Angeles-Angeles; L Llorente; C Castillo; B Pérez; R Rivera; O González; J Rull
Journal:  World J Surg       Date:  1996-01       Impact factor: 3.352

Review 9.  Thyroid cancer.

Authors:  O H Clark; Q Y Duh
Journal:  Med Clin North Am       Date:  1991-01       Impact factor: 5.456

10.  Localized well-differentiated thyroid carcinoma: survival analysis of prognostic factors and (131)I therapy.

Authors:  D M Morris; P J Boyle; C A Stidley; K K Altobelli; T Parnell; C Key
Journal:  Ann Surg Oncol       Date:  1998-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.